The company announced today that its drug, Rinvoq, for treating a type of inflammatory skin condition, was found to be more effective than Regeneron Pharmaceuticals and Sanofi’s Dupixent in a late-stage head-to-head study.
Tag Archive for: skin disease
CEO Hervé Hoppenot said on an investor call that Escient Pharmaceuticals’ two lead assets “address large populations with a clear medical need” with a potential multibillion-dollar market opportunity.
Created in partnership with individuals living with HS and their dermatologists, this new campaign features stories of those living with HS, informational videos, and interactive tools and resources for those seeking management options, daily care, and information about HS.
The experimental drug to treat a type of chronic skin disease was safe and well tolerated in a mid-stage study.